{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T12:29:16Z","timestamp":1648556956017},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1097\/01.jaa.0000473372.47749.16","type":"journal-article","created":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T16:33:54Z","timestamp":1448382834000},"page":"23-26","source":"Crossref","is-referenced-by-count":0,"title":["What are the precautions with proton pump inhibitor use for reflux disease?"],"prefix":"10.1097","volume":"28","author":[{"given":"Cortney M.","family":"Mospan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"3","key":"R1-2-20210130","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ajg.2012.444","article-title":"Guidelines for the diagnosis and management of gastroesophageal reflux disease.","volume":"108","author":"Katz","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"R2-2-20210130","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.bpg.2013.06.001","article-title":"Safety of long-term PPI therapy.","volume":"27","author":"Reimer","year":"2013","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"6","key":"R3-2-20210130","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ajem.2014.03.019","article-title":"Rising rates of proton pump inhibitor prescribing in US emergency departments.","volume":"32","author":"Mazer-Amirshahi","year":"2014","journal-title":"Am J Emerg Med"},{"issue":"1","key":"R4-2-20210130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/CIRCOUTCOMES.114.001177","article-title":"Conflicting results between randomized trials and observational studies on the impact of proton pump inhibitors on cardiovascular events when coadministered with dual antiplatelet therapy: systematic review.","volume":"8","author":"Melloni","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"24","key":"R5-2-20210130","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.296.24.2947","article-title":"Long-term proton pump inhibitor therapy and risk of hip fracture.","volume":"296","author":"Yang","year":"2006","journal-title":"JAMA"},{"issue":"4","key":"R6-2-20210130","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.amjopharm.2012.05.002","article-title":"FDA drug safety communications: a narrative review and clinical considerations for older adults.","volume":"10","author":"Marcum","year":"2012","journal-title":"Am J Geriatr Pharmacother"},{"issue":"6","key":"R7-2-20210130","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11894-010-0141-0","article-title":"Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesium.","volume":"12","author":"Ito","year":"2010","journal-title":"Curr Gastroenterol Rep"}],"container-title":["Journal of the American Academy of Physician Assistants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000473372.47749.16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T18:45:24Z","timestamp":1620931524000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01720610-201512000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":7,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jaa.0000473372.47749.16","relation":{},"ISSN":["1547-1896"],"issn-type":[{"value":"1547-1896","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}